Compass Therapeutics (CMPX) Enterprise Value
Price: $1.75
Market Cap: $241.99M
Avg Volume: 1.65M
Market Cap: $241.99M
Avg Volume: 1.65M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Compass Therapeutics's latest quarterly financial reports:
- The enterprise value (EV) is 223.24M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 198.16M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $1.84, with 137.59M shares outstanding.
- The company has 36.80M in cash and cash equivalents and 6.88M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$223.24M
Market Cap
$253.16M
Total Debt
$6.88M
Cash and Equivalents
$36.80M
Historical Enterprise Value
Compass Therapeutics Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-09-30.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| September 30, 2024 | $223.24M | 99.72% | $1.84 | 137.59M | $253.16M | $36.80M | $6.88M |
| June 30, 2024 | $111.77M | -51.21% | $0.9455 | 137.59M | $130.09M | $19.40M | $1.09M |
| March 31, 2024 | $229.10M | 29.68% | $1.84 | 136.61M | $251.36M | $23.67M | $1.41M |
| December 31, 2023 | $176.67M | -20.65% | $1.56 | 127.67M | $199.16M | $24.23M | $1.73M |
| September 30, 2023 | $222.64M | -42.33% | $1.97 | 127.42M | $251.03M | $30.43M | $2.04M |
| June 30, 2023 | $386.06M | -0.72% | $3.18 | 126.73M | $403.00M | $19.28M | $2.34M |
| March 31, 2023 | $388.86M | -21.77% | $3.27 | 126.38M | $413.25M | $27.03M | $2.64M |
| December 31, 2022 | $497.07M | 129.02% | $5.03 | 105.19M | $529.09M | $34.95M | $2.94M |
| September 30, 2022 | $217.04M | -11.33% | $2.28 | 101.01M | $230.30M | $16.48M | $3.22M |
| June 30, 2022 | $244.77M | 4299.54% | $2.65 | 100.95M | $267.51M | $26.24M | $3.50M |
| March 31, 2022 | $5.56M | -76.90% | $1.37 | 100.86M | $138.18M | $136.38M | $3.77M |
| December 31, 2021 | $24.09M | -87.52% | $3.17 | 51.91M | $164.56M | $144.51M | $4.04M |
| September 30, 2021 | $193.01M | -14.46% | $3.41 | 61.69M | $210.38M | $25.51M | $8.14M |
| June 30, 2021 | $225.64M | -44.81% | $4.75 | 51.91M | $246.59M | $31.21M | $10.26M |
| March 31, 2021 | $408.84M | -15.14% | $8.5 | 51.31M | $436.16M | $39.70M | $12.38M |
| December 31, 2020 | $481.78M | 1.39% | $8.5 | 61.12M | $519.52M | $47.08M | $9.33M |
| September 30, 2020 | $475.19M | 21.65% | $8.5 | 61.12M | $519.52M | $55.52M | $11.19M |
| June 30, 2020 | $390.63M | -11.45% | $8.5 | 52.11M | $442.95M | $65.37M | $13.04M |
| March 31, 2020 | $441.13M | -13.35% | $8.5 | 52.11M | $442.95M | $17.53M | $15.71M |
| December 31, 2019 | $509.09M | 14.93% | $8.5 | 61.12M | $519.52M | $25.30M | $14.87M |
| September 30, 2019 | $442.95M | 0.00% | $8.5 | 52.11M | $442.95M | $882 | $- |
| June 30, 2019 | $442.95M | 342.90% | $8.5 | 52.11M | $442.95M | $4.87K | $- |
| March 31, 2019 | $100.01M | -2137543.90% | $8.5 | 5.00M | $42.50M | $-57.51M | $- |
| December 31, 2018 | $-4.68K | 91.29% | $8.5 | - | $- | $4.68K | $- |
| September 30, 2018 | $-2.45K | -66.17% | $8.5 | - | $- | $2.45K | $- |
| June 30, 2018 | $-7.23K | - | $8.5 | - | $- | $7.23K | $- |
Related Metrics
Explore detailed financial metrics and analysis for CMPX.